Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. logop. foniatr. audiol. (Ed. impr.) ; 39(1): 4-10, ene.-mar. 2019. tab
Artigo em Inglês | IBECS | ID: ibc-176634

RESUMO

Introduction: Preterm and low-birth-weight newborns may present immaturity in the functions of sucking, swallowing and breathing, speech therapists inserted in the hospital focus on the development of newborns' oral sensorimotor system, promoting a safe transition from tube feeding to breastfeeding and contributing to improving the quality of life of the child population. The present study aimed to analyze the development of oral functions, oral feeding transition time and breastfeeding of preterm and low-birth-weight newborns under Speech-Language Pathology care. Methods: A prognostic study carried out at a maternity hospital, based on the data collected from 121 filed medical records of newborns attended between September 2015 to July 2017. The Kaplan-Meier method, the Log Rank test and the Pearson correlation test were used for data analysis, considering a significance level of 0.05 (95%). Results: It was observed that the lower the gestational age and the birth weight of newborns, the more speech therapy services were required until the establishment of exclusive OF; also, the transition time and the average time of using the orogastric tube were inversely proportional to the gestational age at birth. The non-nutritive sucking technique was the most used for stimulation, and 78.5% of the NBs were discharged from the hospital on exclusive breastfeeding. Conclusion: Moderate to late preterm and low-birth-weight newborns are able to more quickly acquire the oral sensorimotor system functional pattern, and there are indications that Speech-Language Pathology care reduces the transition time to oral feeding, thus increasing the success rate of exclusive breastfeeding


Introducción: Los recién nacidos (RN) prematuros y con bajo peso pueden presentar inmadurez en las funciones de succión, deglución y respiración. Los logopedas en los hospitales trabajan el desarrollo del sistema sensoriomotor oral de los RN, promoviendo una transición segura de la sonda a la lactancia materna, lo que contribuye a mejorar la calidad de vida de la población infantil. El objetivo del presente estudio era analizar el desarrollo de las funciones orales, el tiempo de transición a la alimentación por vía oral (VO) y la lactancia materna de los RN prematuros, y con bajo peso al nacer bajo el cuidado fonoaudiológico. Métodos: Este estudio de pronóstico se llevó a cabo en una maternidad, con base en la recopilación de datos en prontuarios archivados de 121 RN atendidos entre septiembre de 2015 y julio de 2017. En el análisis de los datos se aplicó el método de Kaplan-Meier, el test log-rank y la prueba de correlación de Pearson. Se consideró un nivel de significancia de 0,05 (95%). Resultados: Se observó que cuanto menores eran la edad gestacional y el peso de nacimiento del RN, más necesidad de servicios fonoaudiológicos había hasta el establecimiento de la VO exclusiva, y el tiempo de transición y el tiempo promedio de utilización de la sonda orogástrica eran inversamente proporcionales a la edad gestacional al nacimiento. La técnica de succión no nutritiva fue la más utilizada para la estimulación, y el 78,5% de los RN recibieron el alta hospitalaria con lactancia exclusiva. Conclusión: Los RN prematuros de moderados a tardíos y de bajo peso son capaces de adquirir el patrón funcional del sistema sensoriomotor oral con mayor rapidez, y hay indicios de que la atención fonoaudiológica reduce el tiempo de transición alimentaria a la VO, y aumenta la tasa de éxito de lactancia materna exclusiva


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Destreza Motora/fisiologia , Sensação/fisiologia , Fonação/fisiologia , Comportamento de Sucção/fisiologia , Deglutição/fisiologia , Recém-Nascido de Baixo Peso/crescimento & desenvolvimento , Recém-Nascido Prematuro/crescimento & desenvolvimento , Fonoaudiologia/estatística & dados numéricos , Intervenção Médica Precoce/organização & administração , Testes de Função Respiratória/estatística & dados numéricos , Lactação/fisiologia
2.
Artigo em Inglês | MEDLINE | ID: mdl-27601348

RESUMO

OBJECTIVE: Analysis of laryngeal cancer mortality trends in Brazil and its geographic regions for the period 1996-2010 and calculation of mortality predictions for the period 2011-2030. STUDY DESIGN: An epidemiologic, ecologic, demographic-based study, which utilized information from the Mortality Information System on all cancer-related deaths in Brazil, is presented here. Mortality trends were analyzed by Joinpoint regression, and Nordpred was utilized for the calculation of predictions. RESULTS: When comparing the last observed period and the last predicted period for men, an increase of 10,588 deaths is expected, representing an increase of 69%. For women, the expected increase in the number of deaths will be 2217, representing an increase of 104%. Laryngeal cancer mortality rates will increase in the North and Northeast regions for men and in the Northeast and Southeast regions for women. CONCLUSIONS: Despite the current high mortality for laryngeal cancer, rates will continue to increase until 2030 in Brazil.


Assuntos
Neoplasias Laríngeas/mortalidade , Mortalidade/tendências , Adulto , Idoso , Brasil/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco
3.
Salud Publica Mex ; 57(3): 265-74, 2015 May-Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26302130

RESUMO

OBJECTIVE: This study aimed to search the literature for intervention programs in primary care with a multiprofes-sional character, specifically directed at the robust elderly, and with viable and cost-effective interventions. MATERIALS AND METHODS: The search strategies were applied in Cochrane, Lilacs, Pubmed, Scopus, WHOLIS, Embase, Medcarib, SciELO, Web of Science, and PAHO databases. RESULTS: 3 665 articles were found and 32 remained for analysis, grouped into four categories: care management; multidisciplinary intervention; interventions on the basis of risk; and educational interventions with health professionals. CONCLUSION: Strategies such as domestic interventions can promote health and functionality of elderlies, as well as reduce mortality, use of the health system and costs. Besides that, the use of hard and light-hard technologies are important for risk prevention and care management for the elderly.There is a need to create programs for risk prevention and effective management of elderly care at the primary level.


Assuntos
Promoção da Saúde/organização & administração , Serviços de Saúde para Idosos/organização & administração , Atenção Primária à Saúde/organização & administração , Idoso , Idoso de 80 Anos ou mais , Assistência Ambulatorial , Ensaios Clínicos como Assunto , Feminino , Promoção da Saúde/estatística & dados numéricos , Serviços de Saúde/estatística & dados numéricos , Serviços de Saúde para Idosos/estatística & dados numéricos , Visita Domiciliar , Humanos , Comunicação Interdisciplinar , Masculino , Informática Médica , Atenção Primária à Saúde/estatística & dados numéricos , Avaliação de Programas e Projetos de Saúde , Gestão de Riscos/organização & administração , Gestão de Riscos/estatística & dados numéricos
4.
Prog. obstet. ginecol. (Ed. impr.) ; 55(10): 486-491, dic. 2012.
Artigo em Espanhol | IBECS | ID: ibc-107499

RESUMO

Objetivo. Conocer la evolución del cáncer de mama en Aragón, mediante las proyecciones de las tasas de incidencia, prevalencia y mortalidad, durante el periodo de 15 años desde 2008 hasta 2022. Material y métodos. Los datos se han obtenido del Instituto Nacional de Estadística y el programa utilizado ha sido el MIAMOD. Resultados Se estima que entre los años 2008 y el 2022, la tasa de incidencia del cáncer de mama en Aragón disminuirá desde 53,06 hasta 45,56 (ajustada desde 31,66 a 25,22). La mortalidad disminuirá gradualmente de 15,6 en 2008 a 12,93 (8,13 y 6,37, respectivamente) y la prevalencia disminuirá de 568,33 a 522,17 (ajustadas 322,15 a 271,32). Conclusiones. Estas proyecciones indican que la incidencia, la mortalidad y la prevalencia del cáncer de mama en Aragón disminuirán, aunque solo la reducción de la tasa de incidencia lo hará de una forma estadísticamente significativa (AU)


Objective. The aim of this study was to determine the trend in breast cancer in Aragon by projecting the incidence rates, prevalence and mortality over a 15-year period from 2008 to 2022. Material and methods. Data were obtained from the National Institute of Statistics and the program used was the MIAMOD. Results. We estimated that from 2008 to 2022, the incidence rate of breast cancer in Aragon will decrease from 53.06 to 45.56 (adjusted from 31.66 to 25.22). Mortality will decline gradually from 15.6 in 2008 to 12.9 (adjusted from 8.13 to 6.37) and the prevalence will decrease from 568.33 to 522.17 (adjusted from 322.15 to 271.32). Conclusions. These projections indicate that the incidence, mortality and prevalence of breast cancer in Aragon will decrease, although only the reduction in the incidence rate will be statistically significant (AU)


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Neoplasias da Mama/epidemiologia , Neoplasias da Mama/prevenção & controle , Previsões/métodos , Mortalidade/estatística & dados numéricos , Mortalidade Materna/tendências , Espanha/epidemiologia , Mortalidade/normas , Registros de Mortalidade/estatística & dados numéricos
5.
Rev. esp. enferm. dig ; 104(10): 518-523, oct.-nov. 2012. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-107989

RESUMO

Objetivo: estimar la incidencia y la prevalencia del cáncer colorrectal en Aragón, España, basándose en datos de mortalidad y supervivencia del periodo de 1998 a 2007, y proporcionar proyecciones de incidencia, prevalencia y mortalidad hasta el año 2022. Métodos: la mortalidad por todas las causas y para el cáncer colorrectal se obtuvo del Instituto Nacional de Estadística y los datos de supervivencia del estudio EUROCARE. Las estimaciones han sido realizadas utilizándose el programa MIAMOD. El programa Joinpoint ha sido utilizado para cuantificar el cambio anual que se espera en las proyecciones. Resultados: en los hombres, se prevé un aumento de la prevalencia con valor de tasa ajustada de 237,2 (tasa cruda – TC = 303,5) a 273,7 (TC = 412.7) casos por 100.000 habitantes/año en el año 2022. La tasa de incidencia aumentaría de 48,2 (TC = 61,6) a 55,2 (TC = 83,1) casos y la mortalidad de 22,7 (TC = 29,4) a 26,0 (TC = 39,6) al comparar los años de 2007 y 2022. En mujeres se espera una reducción de la prevalencia de 181,5 (TC = 268,3) a 167,9 (TC = 286,2) casos por 100.000 habitantes/año. La tasa de incidencia disminuiría de 25,0 (TC = 38,0) a 22,7 (TC = 39,2) y la mortalidad de 11,3 (TC = 18,0) a 10,3 (TC = 18,5). Conclusión: las proyecciones indican que el cáncer colorrectal en España sigue una tendencia de aumento en la incidencia, mortalidad y prevalencia en hombres y reducción en mujeres. Se necesitan planificar medidas de prevención y tratamiento más efectivas(AU)


Objective: estimate colorectal cancer incidence and prevalence in Aragón, Spain, based on mortality and survival data from the period 1998-2007, and provide projections of incidence, prevalence and mortality until the year 2022. Methods: general and colorectal cancer mortality rates were obtained from the National Statistics Institute and survival data was obtained from the EUROCARE study. Estimations were carried out through the program MIAMOD. The joinpoint program was used to quantify the annual change expected in the projections. Results: in men, an increase in prevalence is expected, from 237.2 (Crude Rate – CR = 303.5) to 237.7 (CR = 412.7) per 100.000 inhabitants/year in 2022. Incidence rates would increase from 48.2 (CR = 61.6) in 2007 to 55.2 (CR = 83.1), and mortality would increase from 22.7 (CR = 29.4) to 26.0 (CR = 39.6) when comparing 2007 and 2022. In women, a reduction in prevalence is expected from 181.5 (CR = 268.3) to 167.9 (CR = 286.2) cases per 100,000 inhabitants/year. Incidence would change from 25.0 (CR = 38.0) in 2007 to 22.7 (CR = 39.2), and for mortality there is also an expected decrease, from 11.3 (CR =18.0) to 10.3 (CR = 18.5). Conclusion: the projections indicate that colorectal cancer in Spain follows an increasing trend in incidence, mortality and prevalence in men, in opposition to corresponding decreasing trends in women. These projections must be considered in order to plan more effective prevention and treatment measures(AU)


Assuntos
Humanos , Masculino , Feminino , Neoplasias Colorretais/epidemiologia , Neoplasias Colorretais/prevenção & controle , Indicadores de Morbimortalidade , Estimativas de População , Espanha/epidemiologia , Previsões , Previsões Demográficas/métodos , Fatores de Risco
6.
Med. clín (Ed. impr.) ; 139(1): 5-9, jun. 2012. tab
Artigo em Espanhol | IBECS | ID: ibc-100985

RESUMO

Fundamento y objetivo: El presente artículo tiene por objetivo estudiar la incidencia y la supervivencia del cáncer esofágico a partir de datos del Registro de Cáncer de Base Poblacional de Zaragoza. Pacientes y método: Fueron calculadas las tasas de incidencia bruta y ajustada de acuerdo con el sexo, y la tendencia de las tasas ajustadas fue analizada a través de la regresión log-linear Joinpoint para el período de 1978 a 2002. La supervivencia observada fue calculada mediante el método Kaplan-Meier. Para el cálculo de la supervivencia relativa se utilizó el cálculo automatizado del Instituto Catalán de Oncología. Resultados: El análisis Joinpoint reveló estabilidad en las tasas de incidencia con porcentaje de cambio anual del 0,16% (intervalo de confianza del 95% [IC 95%] −0,8; 1,1) en varones y 0,04% en mujeres (IC 95% −2,8; 2,8). La supervivencia observada en el período de 1978 a 2002 fue del 33,2% al primer año y 15,3% al quinto año. La supervivencia relativa a 1 año en ambos sexos fue del 36,3% (IC 95% 32,7-40,4) y 23,8% (IC 95% 20,0-28,4) pasados 5 años. Conclusiones: Los datos sugieren que no hubo cambios significativos en las tendencias de incidencia del cáncer esofágico en la provincia de Zaragoza y que la supervivencia fue baja (AU)


Background and objective: The objective of the present paper is to study the incidence and survival of esophageal cancer from data of the Population-Based Cancer Registries of Zaragoza. Patients and methods: Crude and adjusted incidence rates were calculated according to sex and the Joinpoint log-linear regression was utilized to calculate trends in adjusted incidence rates for the period 1978-2002. The observed survival was calculated by utilizing the Kaplan-Meier method. For relative survival, the automate calculation of the Oncology Institute of Catalonia was utilized. Results: Joinpoint analysis revealed stability in the incidence rates with Annual Percentage Change of 0.16 (CI 95%: −0.8; 1.1) for men and 0.04 for women (CI 95%: −2.8; 2.8). Observed survival in the period 1978-2002 was 33.2% in the first year and 15.3% in the last year. Relative 1-year survival for males and females was 36.3% (CI 95%: 32.7-40.4) and 23.8% (CI 95%: 20.0-28.4) after 5 years. Conclusions: Data suggest that there were no significant changes in the incidence rates of esophageal cancer in the province of Zaragoza and that survival was low (AU)


Assuntos
Humanos , Neoplasias Esofágicas/epidemiologia , Incidência , Taxa de Sobrevida , Registros de Doenças/estatística & dados numéricos , Distribuição por Idade e Sexo
7.
Clin Transl Oncol ; 14(3): 221-4, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22374426

RESUMO

OBJECTIVE: This article aims to study larynx cancer survival from the Population-Based Cancer Registry of Zaragoza, Spain, for the period 1978-2002. METHODS: The survival rates were calculated using the Kaplan-Meier method. The automated calculation of the Catalan Institute of Oncology was utilised to obtain the relative survival. RESULTS: The observed survival rate was 84.6% in the first year and 60.9% in the fifth year. The one-year relative survival in both genders was 86.8% (CI 95%: 85.3-88.4) and 70.1% (CI 95%: 67.8-72.4) after five years. Glottic cancer presented a better survival rate than supraglottic and subglottic cancers, and a better survival rate was also observed in younger ages. There were no statistical differences when comparing survival rates by gender and between the periods 1978-1986, 1987-1994 and 1995-2002. CONCLUSIONS: The data suggest there were no significant changes in laryngeal cancer survival in the province of Zaragoza in the period 1978-2002 and that the tumours located in the glottis presented a better prognosis.


Assuntos
Carcinoma de Células Escamosas/mortalidade , Neoplasias de Cabeça e Pescoço/mortalidade , Neoplasias Laríngeas/mortalidade , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/epidemiologia , Criança , Pré-Escolar , Feminino , Neoplasias de Cabeça e Pescoço/epidemiologia , Humanos , Lactente , Recém-Nascido , Neoplasias Laríngeas/epidemiologia , Masculino , Pessoa de Meia-Idade , População , Espanha/epidemiologia , Carcinoma de Células Escamosas de Cabeça e Pescoço , Análise de Sobrevida , Adulto Jovem
8.
Med Clin (Barc) ; 139(1): 5-9, 2012 Jun 02.
Artigo em Espanhol | MEDLINE | ID: mdl-21605877

RESUMO

BACKGROUND AND OBJECTIVE: The objective of the present paper is to study the incidence and survival of esophageal cancer from data of the Population-Based Cancer Registries of Zaragoza. PATIENTS AND METHODS: Crude and adjusted incidence rates were calculated according to sex and the Joinpoint log-linear regression was utilized to calculate trends in adjusted incidence rates for the period 1978-2002. The observed survival was calculated by utilizing the Kaplan-Meier method. For relative survival, the automate calculation of the Oncology Institute of Catalonia was utilized. RESULTS: Joinpoint analysis revealed stability in the incidence rates with Annual Percentage Change of 0.16 (CI 95%: -0.8; 1.1) for men and 0.04 for women (CI 95%: -2.8; 2.8). Observed survival in the period 1978-2002 was 33.2% in the first year and 15.3% in the last year. Relative 1-year survival for males and females was 36.3% (CI 95%: 32.7-40.4) and 23.8% (CI 95%: 20.0-28.4) after 5 years. CONCLUSIONS: Data suggest that there were no significant changes in the incidence rates of esophageal cancer in the province of Zaragoza and that survival was low.


Assuntos
Neoplasias Esofágicas/epidemiologia , Neoplasias Esofágicas/mortalidade , Feminino , Humanos , Incidência , Estimativa de Kaplan-Meier , Modelos Lineares , Masculino , Sistema de Registros , Distribuição por Sexo , Espanha/epidemiologia , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA